The momentum in Congress to act on out-of-control drug prices will continue to build tomorrow, February 12, with a U.S. House Ways and Means Committee hearing entitled, “The Cost of Rising Prescription Drug Prices.”
This hearing, the third held by the new Congress on drug pricing, reinforces the strong, bipartisan interest in Washington to answer the call of the American people to pursue concrete solutions to price gouging from brand name pharmaceutical companies.
A poll released by the National Opinion Research Center at the University of Chicago, in the runup to the 2018 midterm election, found 88 percent of Americans believed lowering drug prices should be a priority in the 116thCongress.
The urgency of the issue and increased activity in Congress has generated new and significant attention from newspapers and influential media outlets around the country – and in the home states of key leaders on committees of jurisdiction.
National Headlines on Big Pharma’s Price Gouging:
House Ways and Means Committee Home-State Headlines:
The Campaign for Sustainable Rx Pricing (CSRxP) is hopeful that these timely hearings in both chambers of Congress will lead to more bipartisan, market-based solutions to lower drug prices and offer much-needed relief to American patients and families struggling to afford their medications.